Results 41 to 50 of about 49,735 (302)

GAD65 Antibody ELISA With Extended Reportable Range: Validation and Guidance for Neurological Practice

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To (1) validate GAD65‐ELISA detection and quantification for type 1 diabetes mellitus and autoimmune neurological diagnoses, (2) correlate ELISA results (reference range < 5 IU/mL) with established radioimmunoprecipitation assay (RIA; ≤ 0.02 nmol/L), and (3) define ELISA clinical utility and pitfalls.
Andrew McKeon, Dana Olofson, Diana Anissian, Divyanshu Dubey, Eoin P. Flanagan, Max C. Herman, Sarosh R. Irani, Daniel H. Lachance, Maria A. Willrich, Sean Pittock, John R. Mills, Anastasia Zekeridou   +11 more
wiley   +1 more source

Understanding Further the Phenotypic Spectrum of Central Nervous System Inflammatory Demyelinating Disorders Using Unsupervised Clustering

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Background Central nervous system (CNS) inflammatory demyelinating syndromes, including multiple sclerosis (MS), aquaporin‐4 antibody–positive neuromyelitis optica spectrum disorder (AQP4 + NMOSD), and myelin oligodendrocyte glycoprotein (MOG) antibody–associated disease (MOGAD), occasionally overlap.
Bade Gulec, Elif Everest, Melih Tutuncu, Ugur Bilge, Sabahattin Saip, Ugur Uygunoglu, Aksel Siva   +6 more
wiley   +1 more source

IVIG Effects on Erythrocyte Sedimentation Rate in Children [PDF]

, 2014
Background. Erythrocyte sedimentation rate (ESR) is a valuable laboratory tool in evaluation of infectious, inflammatory, and malignant diseases. Red blood cells in outside from the body precipitate due to their higher density than the plasma.
صالح زاده, فرهاد, جهانگیری, سپیده, احمدوند, نوشین   +2 more
core   +3 more sources

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease

BMC Pediatrics, 2021
Background Repeated intravenous immunoglobulin (IVIG) resistance prediction is one of the pivotal topics in Kawasaki disease (KD). Those non-responders of repeated IVIG treatment might be improved by an early-intensified therapy to reduce coronary artery
Yaheng Lu, Tingting Chen, Yizhou Wen, Feifei Si, Xindan Wu, Yanfeng Yang   +5 more
doaj   +1 more source

Dimeric IVIG contains natural anti-Siglec-9 autoantibodies and their anti-idiotypes

, 2011
Intravenous immunoglobulin (IVIG) preparations are increasingly used for the treatment of autoimmune and chronic inflammatory diseases. Naturally occurring autoantibodies against Siglec-9 and Fas are thought to contribute to the anti-inflammatory effects
Simon, H-U, S. Wymann, B. M. Stadler, Schaub, A, Stadler, B M, A. Schaub, S. Miescher, M. Spycher, M. Rüegsegger, M. Vogel, von Gunten, S, Rüegsegger, M, S. von Gunten, Wymann, S, Miescher, S, Vogel, M, Spycher, M, H.-U. Simon   +17 more
core   +1 more source

Ofatumumab in Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease: A Comparison With Rituximab

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To evaluate the efficacy and safety of ofatumumab in patients with myelin oligodendrocyte glycoprotein antibody–associated disease (MOGAD), and compare it with rituximab. Methods We conducted a single–center, observational study including 22 MOGAD patients treated with ofatumumab and 21 treated with rituximab.
Yuxin Fan, Lei Zhou, Jingzi ZhangBao, Hongmei Tan, Zhouzhou Wang, Chao Quan   +5 more
wiley   +1 more source

Allergen-specific IgG as a mediator of allergy inhibition: Lessons from mother to child

Human Vaccines & Immunotherapeutics, 2017
Allergen-specific IgG produced by immune mothers is associated with less predisposition to allergy development in their children. This finding has been described by several groups over the last few decades, but the mechanisms by which maternal IgG can ...
Jefferson Russo Victor
doaj   +1 more source

Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients

Italian Journal of Pediatrics, 2023
Background Intravenous immunoglobulin (IVIG) has been the mainstay of treatment for Kawasaki disease (KD) over the past decades. However, 10–20% of KD patients are resistant to IVIG treatment which puts those patients at high risk of coronary artery ...
Rui Zhang, Shuping Shuai, Hongxi Zhang, Jianghui Cai, Na Cui, Mi Tang, Shasha Xing, Yu Gao, Xia Liu, Xiao Yang   +9 more
doaj   +1 more source

Comparative Effectiveness and Safety of Inebilizumab Versus Rituximab in AQP4‐IgG‐Positive NMOSD

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Rituximab (anti‐CD20, RTX) and inebilizumab (anti‐CD19, INE) represent B‐cell‐depleting therapies used for aquaporin‐4 antibody‐positive (AQP4‐IgG+) neuromyelitis optica spectrum disorder (NMOSD); however, direct comparative evidence remains limited.
Jie Lin, Binbin Xue, Dewei Xie, Jia Li, Juyuan Pan, Lanbing Zhu, Qiaowen Tong, Jing Lin, Ruofan Zhu, Xu Zhang, Junhui Xia, Xiang Li   +11 more
wiley   +1 more source

The IVIg Dilemma: A Way Out?

American Journal of Transplantation, 2015
Keywords: editorial / personal viewpoint; immunosuppression / immune modulation; tolerance ...
Gent, Rogier, Kwekkeboom, Jaap
openaire   +3 more sources